It has been suggested that HCC-derived CAFs regulate survival, activation and function of neutrophils within HCC through an IL6-STAT3-PDL1 signaling pathway, which represents a novel mechanism for the role of CAFs in remodeling the cancer niche and provides a potential target for HCC therapy [15]. Here, CD274 is linked to hepatocellular carcinoma.